Source: ThinkstockThe short interest data have been released for the January 29 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through clinical trials. There is a fair ... 24/7 Wall St, 1 day ago
Special 301 review: Pharma's bid to allay IPR concerns - Business Today India, 23 hours ago
Sun Pharma trades higher on the bourses - Finalaya.com, 3 days ago
2 images for "pharma trading company"
Acceleron Pharma Inc (NASDAQ:XLRN) shot up 7.2% on Wednesday , Marketbeat reports. The company traded as high as $26.82 and last traded at $26.40, with a volume of 222,396 shares trading hands. The stock had previously closed at $24.63. A number of ...Ticker Report, 20 hours ago David R. Walt Purchases 9,000 Shares of Cerulean Pharma Inc (CERU) Stock American Banking News - Earnings, 1 day ago Cerulean Pharma Inc (NASDAQ:CERU) Given Average Recommendation of Buy by Brokerages American Banking News - Earnings, 1 day ago David R. Walt Buys 8,563 Shares of Cerulean Pharma Inc (CERU) Stock WKRB News, 1 day ago
Flex Pharma Inc (NASDAQ:FLKS) shares hit a new 52-week low during trading on Wednesday , Market Beat reports. The company traded as low as $6.89 and last traded at $7.38, with a volume of 80,884 shares changing hands. The stock had previously closed ...Ticker Report, 23 hours ago Candriam Luxembourg S.C.A. Acquires 37,800 Shares of Kite Pharma Inc (KITE) American Banking News - Earnings, 3 days ago Kite Pharma Inc (KITE) Hits New 1-Year Low at $38.53 Ticker Report, 1 day ago aTyr Pharma (LIFE) Hits New 52-Week Low at $4.25 Ticker Report, 5 days ago
More from: SleekMoney, WKRB News...and 5 other sources
SENSEX 22951.83 807.07 3.40% NIFTY 6976.35 239.35 3.32% Industry: Medical/Healthcare Company Natco Pharma Ltd Natco Pharma is currently trading at Rs. 452.05, up by 11.60 points or 2.63% from its previous closing of Rs.Finalaya.com, 23 hours ago Sun Pharma Q3 net soars 258% to Rs 1,417 cr Smart Investor, 49 minutes ago
At 11:38 AM, the S&P BSE Sensex is trading at 24,620 up mere three points, while NSE Nifty is trading at 7,495 up five points. The BSE Mid-cap Index is trading up 0.95% at 10,433, whereas BSE Small-cap Index is trading up 0.93% at 10,667. Some ...India Infoline, 4 days ago Nifty trades below 7300 India Infoline, 3 days ago Sensex, Nifty choppy India Infoline, 5 hours ago Global sell-off casts shadow on D-Street Rediff.com, 3 days ago
SENSEX 22799.61 152.22 0.66% NIFTY 6931.20 45.15 0.65% Industry: Medical/Healthcare Company Aurobindo Pharma Ltd Aurobindo Pharma is currently trading at Rs. 648.80, up by 7.20 points or 1.12% from its previous closing of Rs.Finalaya.com, 5 hours ago Dr Reddy's gets USFDA nod to market Sernivo spray Asian Age, 4 days ago Aurobindo Pharma gets USFDA nod for Isosulfan Blue injection The Financial Chronicle, 1 week ago Aurobindo Pharma receives USFDA nod for generic drug Economic Times, 1 month ago
NEW DELHI: Stock prices of leading Indian pharmaceutical companies dropped today after reports indicated new US norms mandating companies to use locally manufactured bulk drugs for procurement by the government . Bulk drugs, or active ...Economic Times, 1 week ago BIOSTAR PHARMACEUTICALS : to Effect Reverse Stock Split 4 Traders, 14 hours ago Why pharma stocks took a beating on Dalal Street Business Today India, 1 week ago Pharma stocks drop on worries new US rule will hit pharma exports Capital Market, 1 week ago
Aurobindo Pharma , pharmaceutical research company, reported consolidated net profit of Rs. 534.95 crore for the quarter ended December 31, 2015, registering growth of 39.18% yoy and 18.41% qoq. The company's revenue stood at Rs. 3,495.50 crore, up ...India Infoline, 2 days ago Glaxosmithkline Pharma Ltd India Infoline, 1 day ago Glaxo, Auro Pharma and Dr Reddy's to report better topline in December quarter: Angel Broking International Business Times India, 3 days ago AstraZeneca Pharma India surges after turnaround Q3 result Capital Market, 4 days ago
More from: , Jagran Post...and 2 other sources
The Special 301 Report is an annual review of the state of IPR protection and enforcement in trading partners of US, and identifies challenges and opportunities facing US companies in foreign markets. The hearings on the issue will start in March.MyInforms, 3 days ago US pharma body calls for stronger protection of intellectual property rights in India Livemint.com, 1 day ago US pharma body criticizes Indian patent regime Livemint.com, 2 days ago
4D pharma plc, a pharmaceutical company focusing on the development of live biotherapeutics, is pleased to announce that it has today acquired the entire issued share capital of Tucana Health Limited ("Tucana"). Recent advances have highlighted ...Pharma Focus Asia, 1 day ago 4D pharma plc Acquisition FierceBiotech, 13 hours ago
on your WebpageAdd Widget >Get your members hooked!